By ANISH KOKA, MD A number of politically tinged narratives have divided physicians during the pandemic. It would be unfortunate if politics obscured the major problem brought into stark relief by the pandemic: a system that marginalizes physicians and strips them of agency. In practices big and small, hospital-employed or private practice, nursing homes or… Read More: COVID-19: Physicians in Shackles »
The hopeful buzz around the drug Remdesivir and its potential as a COVID-19 treatment was so deafening Wednesday, it triggered an unexpected surge in the financial markets. New evidence “has proven … that a drug can block this virus,” enthused Dr. Anthony Fauci, the U.S. government’s top infectious disease expert. But Canadian experts were not… Read More: More data, supply needed before making promising COVID-19 drug Remdesivir… »
As the novel coronavirus swept through communities around the world, preying disproportionately on the poor and the vulnerable, one disadvantaged group has demonstrated a remarkable resistance. Women, whether from China, Italy or the U.S., have been less likely to become acutely ill — and far more likely to survive. Which has made doctors wonder: Could… Read More: Can Estrogen and Other Sex Hormones Help Men Survive Covid-19? »
The federal Coronavirus Aids, Relief and Economic Security (CARES) Act, which President Trump signed into law March 27, includes $ 155 million for HIV programs. According to the Kaiser Family Foundation, this breaks down into $ 90 million for the Ryan White HIV/AIDS Program and $ 65 million for the Housing for People with AIDS… Read More: $155M in Federal COVID-19 Relief Funds Goes to HIV Programs »